HQH has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
HQH has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. As of today (2025-03-24), abrdn Healthcare Investors's share price is $16.835. abrdn Healthcare Investors's Book Value per Share for the quarter that ended in Sep. 2024 was $20.33. Hence, abrdn Healthcare Investors's PB Ratio of today is 0.83.
Good Sign:
abrdn Healthcare Investors stock PB Ratio (=0.82) is close to 2-year low of 0.76
The historical rank and industry rank for abrdn Healthcare Investors's PB Ratio or its related term are showing as below:
During the past 8 years, abrdn Healthcare Investors's highest PB Ratio was 1.12. The lowest was 0.65. And the median was 0.89.
During the past 12 months, abrdn Healthcare Investors's average Book Value Per Share Growth Rate was 7.90% per year. During the past 3 years, the average Book Value Per Share Growth Rate was -7.20% per year. During the past 5 years, the average Book Value Per Share Growth Rate was -2.80% per year.
During the past 8 years, the highest 3-Year average Book Value Per Share Growth Rate of abrdn Healthcare Investors was -0.20% per year. The lowest was -7.80% per year. And the median was -2.60% per year.
The historical data trend for abrdn Healthcare Investors's PB Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
abrdn Healthcare Investors Annual Data | |||||||||||||||||
Trend | Sep17 | Sep18 | Sep19 | Sep20 | Sep21 | Sep22 | Sep23 | Sep24 | |||||||||
PB Ratio | Get a 7-Day Free Trial | 0.86 | 1.00 | 0.89 | 0.83 | 0.92 |
abrdn Healthcare Investors Semi-Annual Data | |||||||||||||||
Sep17 | Mar18 | Sep18 | Mar19 | Sep19 | Mar20 | Sep20 | Mar21 | Sep21 | Mar22 | Sep22 | Mar23 | Sep23 | Mar24 | Sep24 | |
PB Ratio | Get a 7-Day Free Trial |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
0.89 | 0.87 | 0.83 | 0.85 | 0.92 |
For the Asset Management subindustry, abrdn Healthcare Investors's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
For the Asset Management industry and Financial Services sector, abrdn Healthcare Investors's PB Ratio distribution charts can be found below:
* The bar in red indicates where abrdn Healthcare Investors's PB Ratio falls into.
The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. It is a ratio widely used to value stocks.
abrdn Healthcare Investors's PB Ratio for today is calculated as follows:
PB Ratio | = | Share Price | / | Book Value per Share (Q: Sep. 2024) |
= | 16.835 | / | 20.326 | |
= | 0.83 |
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
PB Ratio | = | Market Cap | / | (Total Stockholders Equity | - | Preferred Stock) |
A closely related ratio is called Price-to-Tangible-Book. The difference between Price-to-Tangible-Book and PB Ratio is that book value other than intangibles are used in the calculation.
abrdn Healthcare Investors (NYSE:HQH) PB Ratio Explanation
Unlike valuation ratios relative to the earning power such as PE Ratio, PE Ratio without NRI, PS Ratio, Price-to-Operating-Cash-Flow , or Price-to-Free-Cash-Flow, the PB Ratio measures the valuation of the stock relative to the underlying asset of the company.
The PB Ratio works the best for the businesses that earn most of their profit from their assets, e.g. banks and insurance companies.
Be Aware
Some businesses have very light assets, such as software companies or insurance agencies. The PB Ratio does not work well for these companies. Some companies even have negative equity, so the PB Ratio cannot be applied to them.
Thank you for viewing the detailed overview of abrdn Healthcare Investors's PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.
Rose Dimartino | director | C/O ABRDN, 1900 MARKET STREET, PHILADELPHIA PA 19103 |
Kathleen Goetz | director | 1310 OAK VALLEY CIRCLE, POLK CITY IA 50226 |
Todd Reit | director | C/O ABERDEEN STANDARD INVESTMENTS, 1900 MARKET STREET, SUITE 200, PHILADELPHIA PA 19103 |
Bill Maher | director | 600 WEST BROADWAY, 30TH FL., SAN DIEGO CA 92101 |
Alan R Goodson | officer: Vice President | 1735 MARKET STREET, 32ND FLOOR, PHILADELPHIA PA 19103 |
James Joseph O'connor | other: Director of Adviser | C/O ABERDEEN STANDARD INVESTMENTS, 1900 MARKET STREET, SUITE 200, PHILADELPHIA PA 19103 |
Marika Tooze | other: Director of Adviser | C/O ABRDN, 1900 MARKET STREET, SUITE 200, PHILADELPHIA PA 19103 |
Aberdeen Standard Investments Inc. | other: Adviser | 1900 MARKET ST., 2ND FLOOR, PHILADELPHIA PA 19103 |
Jaclyn Marie Matsick | other: Director of Adviser | C/O ABRDN, 1900 MARKET STREET, SUITE 200, PHILADELPHIA PA 19103 |
Lucia Sitar | officer: VP and Chief Legal Officer | 1735 MARKET STREET, 32ND FLOOR, PHILADELPHIA PA 19103 |
Jennifer A Nichols | other: Director of Adviser | 1735 MARKET STREET, 37TH FLOOR, PHILADELPHIA PA 19103 |
Christian Pittard | officer: President | ONE BOW CHURCHYARD, LONDON X0 EC4M 9HH |
Megan Kennedy | officer: Secretary and Vice President | 1735 MARKET STREET, 32ND FLOOR, PHILADELPHIA PA 19103 |
Sharon Ferrari | officer: Treasurer and CFO | 1735 MARKET STREET, 32ND FLOOR, PHILADELPHIA PA 19103 |
Joseph Andolina | officer: Chief Compliance Officer & VP | 1735 MARKET STREET, 32ND FLOOR, PHILADELPHIA PA 19103 |
From GuruFocus
By Business Wire Business Wire • 03-31-2022
By Business Wire • 06-30-2023
By GuruFocus News • 10-23-2024
By GuruFocus Research • 09-26-2023
By Business Wire Business Wire • 06-30-2022
By Business Wire Business Wire • 02-15-2022
By Business Wire Business Wire • 12-31-2021
By Business Wire • 10-05-2023
By Business Wire Business Wire • 06-20-2023
By Business Wire Business Wire • 11-15-2022
Disclaimers: GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes provided by InterActive Data. Fundamental company data provided by Morningstar, updated daily.